0J4V Stock Price, Chart, Stats & News

Heron Therapeutics, Inc.
Save
Heron Therapeutics, Inc. (0J4V) does not currently pay a dividend.
52.12M
Market cap
–
Current P/E
–
Forward P/E
0J4V chart
About
Health care
Sector
Biotechnology
Industry
Heron Therapeutics, Inc. is a biotechnology firm dedicated to developing innovative therapeutic solutions for significant unmet patient needs. At the heart of its pipeline is the proprietary Biochronomer drug delivery system. This technology enables the sustained release of various short-acting pharmacological agents, maintaining therapeutic levels for several days to weeks following a single administration.
Similar securities
Based on sector and market capitalization
Report issue





